{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:29:18Z","timestamp":1773296958449,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.nucmedbio.2005.04.014","type":"journal-article","created":{"date-parts":[[2005,7,17]],"date-time":"2005-07-17T12:33:11Z","timestamp":1121603591000},"page":"573-583","source":"Crossref","is-referenced-by-count":16,"title":["Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin"],"prefix":"10.1016","volume":"32","author":[{"given":"Zhonglin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail D.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison H.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars R.","family":"Furenlid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Kastis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bettan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Woolfenden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2005.04.014_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJM198705283162207","article-title":"Multiple-drug resistance in human cancer","volume":"316","author":"Pastan","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/07853899509031953","article-title":"The genetic basis of resistance to cancer chemotherapy","volume":"27","author":"Woodhouse","year":"1995","journal-title":"Ann Med"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib3","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1016\/S0021-9258(18)37730-5","article-title":"The multidrug transporter, a double-edged sword","volume":"263","author":"Gottesman","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib4","first-page":"5435","article-title":"Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers","volume":"56","author":"Abbaszadegan","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1097-0320(19980601)32:2<86::AID-CYTO3>3.0.CO;2-C","article-title":"Cytometric study of intracellular P-gp expression and reversal of drug resistance","volume":"32","author":"Labroille","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib6","first-page":"5902","article-title":"Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells","volume":"54","author":"Cole","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib7","first-page":"459","article-title":"Sequential coexpression of the multidrug resistance genes MRP and MDR1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells","volume":"55","author":"Brock","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib8","first-page":"4226","article-title":"In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833","volume":"51","author":"Boesch","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib9","first-page":"545","article-title":"Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi","volume":"3","author":"Chen","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib10","first-page":"2349","article-title":"99mTc-sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours","volume":"19","author":"Bakker","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00006231-199504000-00156","article-title":"99mTc-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant","volume":"16","author":"Ballinger","year":"1995","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1054\/bjoc.2000.1621","article-title":"Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function","volume":"84","author":"Muzzammil","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.thj.6200050","article-title":"Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia","volume":"1","author":"Sonneveld","year":"2000","journal-title":"Hematol J"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1097-0142(20010915)92:6<1577::AID-CNCR1484>3.0.CO;2-H","article-title":"A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)","volume":"92","author":"Bates","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/carcin\/bgh018","article-title":"Effect of PSC 833, an inhibitor of P-glycoprotein on N-methyl-N-nitrosourea induced mammary carcinogenesis in rats","volume":"25","author":"Kankesan","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-5793(98)00744-3","article-title":"The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation","volume":"431","author":"Cabot","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib17","first-page":"880","article-title":"SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells","volume":"59","author":"Cabot","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<300::AID-CNCR14>3.0.CO;2-H","article-title":"Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells","volume":"86","author":"Lucci","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<389::AID-IJC19>3.0.CO;2-5","article-title":"Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells","volume":"65","author":"Hwang","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0969-8051(97)00201-1","article-title":"99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo","volume":"25","author":"Bernard","year":"1998","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib21","first-page":"977","article-title":"Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex","volume":"53","author":"Piwnica-Worms","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib22","first-page":"1915","article-title":"Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors","volume":"38","author":"Ballinger","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00006231-199902000-00002","article-title":"99mTc-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer","volume":"20","author":"Muzzammil","year":"1999","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib24","first-page":"1467","article-title":"Technetium-99m tetrofosmin mammoscintigraphy findings related to the expression of P-glycoprotein mediated multidrug resistance","volume":"20","author":"Sun","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/cbr.2000.15.339","article-title":"In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors","volume":"15","author":"Muzzammil","year":"2000","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/cbr.2000.15.327","article-title":"Scintigraphic detection of multidrug resistance in cancer","volume":"15","author":"Del Vecchio","year":"2000","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF02439547","article-title":"In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m-sestamibi scan in untreated breast cancer patients","volume":"24","author":"Del Vecchio","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib28","first-page":"1578","article-title":"Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells","volume":"37","author":"Ballinger","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/bjc.1991.202","article-title":"Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line","volume":"63","author":"Taylor","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib30","first-page":"276","article-title":"Characterization of P-glycoprotein transport and inhibition in vivo","volume":"58","author":"Barbarics","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0969-8051(03)00119-7","article-title":"Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system","volume":"31","author":"Liu","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib32","doi-asserted-by":"crossref","first-page":"15544","DOI":"10.1016\/S0021-9258(18)66748-1","article-title":"Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells","volume":"261","author":"Batist","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0959-8049(99)00288-9","article-title":"Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein","volume":"36","author":"Benderra","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1097-0320(20000901)41:1<62::AID-CYTO9>3.0.CO;2-7","article-title":"Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles","volume":"41","author":"Merlin","year":"2000","journal-title":"Cytometry"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib35","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1007\/s002590000375","article-title":"Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line","volume":"27","author":"Utsunomiya","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib36","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1021\/bi00122a014","article-title":"Lipophilic cations: a group of model substrates for the multidrug-resistance transporter","volume":"31","author":"Gros","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0006-2952(00)00341-5","article-title":"Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP\/MXR\/ABCP on the transport of (99m)Tc-tetrofosmin","volume":"60","author":"Chen","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.nucmedbio.2005.04.014_bib38","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1177\/009127001773744143","article-title":"99mTc-tetrofosmin for functional imaging of P-glycoprotein modulation in vivo","author":"Ballinger","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0969-8051(02)00333-5","article-title":"Tc-99m-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow","volume":"29","author":"Mankoff","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00259-001-0705-1","article-title":"Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging","volume":"29","author":"Tatsumi","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-2952(01)00642-6","article-title":"Effects of the novel cyclosporine derivative PSC833 on glucose metabolism in rat primary cultures of neuronal and glial cells","volume":"62","author":"Cruz","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(01)00406-0","article-title":"Effect of PSC 833 liposomes and intralipid on the transport of epirubicin in Caco-2 cells and rat intestines","volume":"76","author":"Lo","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/02841869509093961","article-title":"Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo","volume":"34","author":"Watanabe","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.nucmedbio.2005.04.014_bib44","first-page":"2885","article-title":"The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR)","volume":"19","author":"Krishna","year":"1999","journal-title":"Anticancer Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805105001186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805105001186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T17:42:54Z","timestamp":1626198174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805105001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0969805105001186"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2005.04.014","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}